1811 - 1820 of 9148 Results
Title
Year
-
OPENTitle: Stability Evaluation of Brain Changes in Parkinson's Disease Based on Machine LearningJournal Name: Frontiers in Computational NeurosciencePublisher: Frontiers Media SAVol: 15Issue #:Start Page: 735991End Page: 735991Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fncom.2021.735991Best OA location URL: https://www.frontiersin.org/articles/10.3389/fncom.2021.735991/pdfCitation Count: 14
-
OPENTitle: Mitochondrial Defects in Fibroblasts of Pathogenic MAPT PatientsJournal Name: Frontiers in Cell and Developmental BiologyPublisher: Frontiers Media SAVol: 9Issue #:Start Page: 765408End Page: 765408Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fcell.2021.765408Best OA location URL: https://doi.org/10.3389/fcell.2021.765408Citation Count: 10
-
OPENTitle: Structural basis of polyamine transport by human ATP13A2 (PARK9)Journal Name: Molecular CellPublisher: Elsevier BVVol: 81Issue #: 22Start Page: 4635End Page: 4649.e8Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.molcel.2021.08.017Best OA location URL: https://escholarship.org/content/qt0vq3x5sc/qt0vq3x5sc.pdfCitation Count: 49
-
OPENTitle: The Added Benefit of Opicapone When Used Early in Parkinson's Disease Patients With Levodopa-Induced Motor Fluctuations: A Post-hoc Analysis of BIPARK-I and -IIJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 12Issue #:Start Page: 754016End Page: 754016Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2021.754016Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2021.754016/pdfCitation Count: 18
-
OPENTitle: Glucosylceramide in cerebrospinal fluid of patients with GBA-associated and idiopathic Parkinson’s disease enrolled in PPMIJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page: 102End Page: 102Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-021-00241-3Best OA location URL: https://www.nature.com/articles/s41531-021-00241-3.pdfCitation Count: 55
-
OPENTitle: Blood transcriptomic signatures associated with molecular changes in the brain and clinical outcomes in Parkinson’s diseaseJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 14Issue #: 1Start Page: 3956End Page: 3956Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-023-39652-6Best OA location URL: https://www.nature.com/articles/s41467-023-39652-6.pdfCitation Count: 56
-
OPENTitle: Decrease in Skin Prion-Seeding Activity of Prion-Infected Mice Treated with a Compound Against Human and Animal Prions: a First Possible Biomarker for Prion TherapeuticsJournal Name: Molecular NeurobiologyPublisher: Springer Science and Business Media LLCVol: 58Issue #: 9Start Page: 4280End Page: 4292Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s12035-021-02418-6Best OA location URL: https://link.springer.com/content/pdf/10.1007/s12035-021-02418-6.pdfCitation Count: 21
-
OPENTitle: Contribution of rare variant associations to neurodegenerative disease presentationJournal Name: npj Genomic MedicinePublisher: Springer Science and Business Media LLCVol: 6Issue #: 1Start Page: 80End Page: 80Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41525-021-00243-3Best OA location URL: https://www.nature.com/articles/s41525-021-00243-3.pdfCitation Count: 22
-
OPENTitle: Carlos II of Spain, ‘The Bewitched’: cursed by aspartylglucosaminuria?Journal Name: BMJ Neurology OpenPublisher: BMJVol: 3Issue #: 2Start Page: e000072End Page: e000072Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1136/bmjno-2020-000072Best OA location URL: https://neurologyopen.bmj.com/content/bmjno/3/2/e000072.full.pdfCitation Count: 1
- The AKT modulator A-443654 reduces α-synuclein expression and normalizes ER stress and autophagy2021OPENTitle: The AKT modulator A-443654 reduces α-synuclein expression and normalizes ER stress and autophagyJournal Name: Journal of Biological ChemistryPublisher: Elsevier BVVol: 297Issue #: 4Start Page: 101191End Page: 101191Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.jbc.2021.101191Best OA location URL: http://www.jbc.org/article/S0021925821009935/pdfCitation Count: 40